Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the details of meetings to be held with Analysts/Institutional investors Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the details of meetings to be held with Analysts/Institutional investors. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the details of meetings to be held with Analysts/Institutional investors. Syngene International Ltd - 539268 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby attach the Annual Secretarial Compliance Report for the year ended March 31, 2023, issued by CS Devika Sathyanarayana, Partner of V. Sreedharan & Associates, Secretarial Auditors of the Company. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the details of meetings to be held with Analysts/Institutional investors. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of meetings to be held with Analysts/Institutional investors Syngene International Ltd - 539268 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Syngene International Ltd 2 CIN NO. L85110KA1993PLC014937 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2022-23, FY 2023-24 & FY 2024-25 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2022-23, FY 2023-24 & FY 2024-25 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Priyadarshini MahapatraDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Sibaji Biswas Designation : -Chief Financial...
CRO market still very much untapped in India: Cyndrella Carvalho
Indian CROs and CDMOs are attracting a lot of attention as companies, such as Syngene, Suven, and Divis, create long-term relationships with top pharma organisations. According to Cyndrella Carvalho of JM Financial, India still has a vital untapped CRO market, and with its large and diverse population, it offers enormous potential for growth in medical research. The market is so tight that even larger unlisted businesses, such as India's Aragen, are making a name for themselves. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please find the link for the transcript of the Q4 FY23 Earnings Call conducted on April 27, 2023, and uploaded on the website of the Company on May 3, 2023
Big Movers on D-St: What should investors do with Syngene International, REC and EIH?
Sectorally, buying was seen in telecom, capital goods, utilities, public sector and power stocks while selling was seen in consumer durables. Stocks that were in focus include names like Syngene International which rose more than 4%, EIH rallied nearly 10% and REC closed with gains of over 5% on Friday.